Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November,
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.
Vertex Pharmaceuticals (VRTX) Set for Painless Gains After FDA Approval
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare
FDA Approves the First Non-Opioid Pain Medicine in 20 Years
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals,
2h
on MSN
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
FiercePharma
1d
Trump tariffs threaten US drug supplies and risk higher prices, trade groups warn
“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...
RiverBender.com
1d
Durbin, Grassley Urge PhRMA To Embrace Their Bill To End Price Secrecy In Prescription Drug Advertisements
CHICAGO U.S. Senate Democratic Whip Dick Durbin (D-IL) and U.S. Senator Chuck Grassley (R-IA), a senior member and former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
RFK Jr. clears Senate panel
Imposes tariffs on US goods
Pauses tariffs on Canada, MX
Antitrust violation probe
New York shields prescribers
Southern border visit
Sued by former nanny
Accused attacker faces trial
'Special govt. employee'
2025 'Cowboy Carter' tour
Highway reopens after fires
To block Trump nominees
Biden signs with CAA
Offers to jail US criminals
MLB fires Pat Hoberg
Fund freeze block extended
Suspended 10 games
Senate confirms Wright
Microplastics found in brains
Sued for discrimination
‘Squid Game' actress dies
DOJ to battle antisemitism
EPA warns employees
FSU coach stepping down
Inks deal with SK’s Kakao
Stradivarius violin auction
Recall upgraded to Class I
Garrett requests trade
US, Philippines joint patrol
Former Astros coach dies
Feedback